Literature DB >> 9520955

The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease.

W E Cunningham1, R D Hays, M K Ettl, W J Dixon, R C Liu, C K Beck, M F Shapiro.   

Abstract

OBJECTIVES: This study examined the prospective effect of reported access to medical care on health-related quality-of-life outcomes in patients with symptomatic human immunodeficiency virus (HIV) disease.
METHODS: A cohort study was designed with interviews at baseline, follow-up interviews at 3 months after baseline, mortality follow-up through 6 months after baseline, and medical record reviews for selected baseline clinical data. Participants were HIV-infected patients who were receiving ambulatory and/or hospital care at one county-run municipal and one Veterans Administration hospital in metropolitan Los Angeles and were interviewed about access to medical care (using a reliable 9-item scale assessing affordability, availability, and convenience of medical care). Access to care reported by this sample was compared with that of 2,471 patients with other chronic diseases from the Medical Outcomes Study. The main outcome measures were composite scores for physical and mental health-related quality of life 3 months after baseline, derived from a validated 56-item instrument, scored from 0 to 100, and controlling for baseline health-related quality of life.
RESULTS: Overall reported access to medical care in this sample was significantly poorer than that for patients with other chronic diseases (means scores were 63 and 73, respectively). The sample was categorized into tertiles of initial physical and mental health-related quality of life and into groups with initial high versus low access to care. Among those in the middle tertile of physical health-related quality of life at baseline, those with high access improved in physical health scores by 10.2 points relative to those with low access. Those in the low and middle tertiles of initial mental health improved in mental health to a significantly greater extent for those with high versus low access. There were nonsignificant trends toward similar effects for most other subgroups. The effects of access on health-related quality-of-life outcomes were generally robust in multivariate regression analyses that included CD4, hemoglobin, albumin, insurance status, and sociodemographic characteristics.
CONCLUSIONS: Access to care at baseline predicted better physical and mental health outcomes at 3 months for those in the middle tertile of physical health and for those in the bottom and middle tertiles of mental health at baseline. Increasing access to care for poor public hospital patients with HIV infection may help to improve health-related quality-of-life outcomes among selected persons with advanced disease.

Entities:  

Mesh:

Year:  1998        PMID: 9520955     DOI: 10.1097/00005650-199803000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  17 in total

1.  Community, service, and policy strategies to improve health care access in the changing urban environment.

Authors:  D P Andrulis
Journal:  Am J Public Health       Date:  2000-06       Impact factor: 9.308

2.  Factors associated with HIV viral load in a respondent driven sample in Los Angeles.

Authors:  William D King; Sherry Larkins; Christopher Hucks-Ortiz; Pin-Chieh Wang; Pamina M Gorbach; Rose Veniegas; Steven Shoptaw
Journal:  AIDS Behav       Date:  2007-12-07

3.  Differential relationships between social adversity and depressive symptoms by HIV status and racial/ethnic identity.

Authors:  Timothy J Williamson; Zanjbeel Mahmood; Taylor P Kuhn; April D Thames
Journal:  Health Psychol       Date:  2016-12-08       Impact factor: 4.267

4.  Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.

Authors:  Ank E Nijhawan; Lisa R Metsch; Song Zhang; Daniel J Feaster; Lauren Gooden; Mamta K Jain; Robrina Walker; Shannon Huffaker; Michael J Mugavero; Petra Jacobs; Wendy S Armstrong; Eric S Daar; Meg Sullivan; Carlos Del Rio; Ethan A Halm
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.731

Review 5.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

7.  Additive effects of numbness and muscle aches on fatigue occurrence in individuals with HIV/AIDS who are taking antiretroviral therapy.

Authors:  Dean J Wantland; Joseph P Mullan; William L Holzemer; Carmen J Portillo; Suzanne Bakken; Eva M McGhee
Journal:  J Pain Symptom Manage       Date:  2011-01-13       Impact factor: 3.612

8.  Barriers to Care Among Transgender and Gender Nonconforming Adults.

Authors:  Gilbert Gonzales; Carrie Henning-Smith
Journal:  Milbank Q       Date:  2017-12       Impact factor: 4.911

9.  The association of access to medical care with regular source of care and sociodemographic characteristics in patients with HIV and tuberculosis.

Authors:  M Rosa Solorio; Steven M Asch; Denise Globe; William E Cunningham
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

Review 10.  Interventions to promote linkage to and utilization of HIV medical care among HIV-diagnosed persons: a qualitative systematic review, 1996-2011.

Authors:  Adrian Liau; Nicole Crepaz; Cynthia M Lyles; Darrel H Higa; Mary M Mullins; Julia DeLuca; Sarah Petters; Gary Marks
Journal:  AIDS Behav       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.